2025 ACIP Immunization Schedules

News
Article
Drug Topics JournalDrug Topics January/February 2025
Volume 169
Issue 01

More detailed information can be found on the CDC’s website at www.cdc.gov/vaccines.

Another new year means another update to the CDC’s Advisory Committee on Immunization Practices (ACIP) immunization schedules.1 In 2024, ACIP made a number of changes to vaccine recommendations, including a new 21-valent pneumococcal conjugate vaccine, new respiratory syncytial virus vaccines for adults and pregnant women, and more.

The following tables have been created using the CDC’s recommended immunization schedules for 2025.

To read these stories and more, download the PDF of the Drug Topics January/February issue here.

Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Sign up today for our free Drug Topics newsletter.

Reference
Immunization schedules. CDC. November 21, 2024. Accessed January 27, 2025. https://www.cdc.gov/vaccines/hcp/imz-schedules/index.html
Download Issue PDF
Articles in this issue
2025 ACIP Immunization Schedules
2025 ACIP Immunization Schedules
New Drug Review: FDA Approves Tryvio for the Treatment of Hypertension in Combination With Other Antihypertensive Drugs to Lower Blood Pressure
New Drug Review: FDA Approves Tryvio for the Treatment of Hypertension in Combination With Other Antihypertensive Drugs to Lower Blood Pressure
OTC Roundup: Digestive Health Products
OTC Roundup: Digestive Health Products
Q&A: The Pharmacist’s Ability to Provide Nutritional Guidance
Q&A: The Pharmacist’s Ability to Provide Nutritional Guidance
FDA Requires Abrysvo, Arexvy RSV Vaccine Labels to Include Guillain-Barré Warning
FDA Requires Abrysvo, Arexvy RSV Vaccine Labels to Include Guillain-Barré Warning
Mediterranean, DASH Remain Supreme Among Other Dietary Regimens
Mediterranean, DASH Remain Supreme Among Other Dietary Regimens
Q&A: Challenges, Barriers Impacting Glucagon Prescribing
Q&A: Challenges, Barriers Impacting Glucagon Prescribing
Examining Impact of Continuous Glucose Monitors on Diabetes | ASHP Midyear
Examining Impact of Continuous Glucose Monitors on Diabetes | ASHP Midyear
Q&A: Educating Patients, Providers to Increase Biosimilar Implementation | ASHP Midyear
Q&A: Educating Patients, Providers to Increase Biosimilar Implementation | ASHP Midyear
Q&A: Importance of Managing Comorbidities for Patients with MASLD | ASHP Midyear
Q&A: Importance of Managing Comorbidities for Patients with MASLD | ASHP Midyear
Q&A: Statin, Nonstatin Combination Therapy to Treat Patients’ Cardiovascular Risk | ASHP Midyear
Q&A: Statin, Nonstatin Combination Therapy to Treat Patients’ Cardiovascular Risk | ASHP Midyear
In A Warming World, Climate-Resilient Health Care Delivery Is Key | ASHP Midyear
In A Warming World, Climate-Resilient Health Care Delivery Is Key | ASHP Midyear
HIV Treatment, PrEP Have Come a Long Way, With More Work To Be Done | ASHP Midyear
HIV Treatment, PrEP Have Come a Long Way, With More Work To Be Done | ASHP Midyear
Pharmacist-Led Care Leads to Better Outcomes in ASCVD | ASHP Midyear
Pharmacist-Led Care Leads to Better Outcomes in ASCVD | ASHP Midyear
Navigating Cannabis Use in Health Care Settings | ASHP Midyear
Navigating Cannabis Use in Health Care Settings | ASHP Midyear
Recent Videos
Related Content
FDA Grants Fast Track Designation to mRNA Vaccine Candidate for Chlamydia

FDA Grants Fast Track Designation to mRNA Vaccine Candidate for Chlamydia

Ashley Gallagher
March 28th 2025
Article

Currently, there is no vaccine to prevent chlamydia, but treatment includes regimens of antibiotics, including doxycycline, azithromycin, and levofloxacin.

pharmacist holds prescription packet

Good Neighbor Pharmacy Customers Across the US Reflect and Look Forward

September 20th 2021
Podcast

Good Neighbor Pharmacy customers from rural, suburban, and city areas reflect on the past year and discuss the future of independent pharmacy.

Pharmacists’ Role in Addressing Vaccine Barriers Among Underserved Communities | APhA 2025

Pharmacists’ Role in Addressing Vaccine Barriers Among Underserved Communities | APhA 2025

Brian Nowosielski
March 25th 2025
Article

Chichi Ilonzo Momah, PharmD, discussed what pharmacists can be doing to address vaccine hesitancy and the barriers impeding under-resourced communities.

COVID-19 mRNA Vaccines May Reduce Long COVID Risk in Children, Adolescents

COVID-19 mRNA Vaccines May Reduce Long COVID Risk in Children, Adolescents

Killian Meara
March 11th 2025
Article

COVID-19 vaccination before a SARS-CoV-2 infection was associated with a 75% reduced likelihood of long COVID symptoms that impact daily functioning among patients between the ages of 5 and 17 years.

State Immunization Policies for Pharmacists Hinder US Vaccine Uptake

State Immunization Policies for Pharmacists Hinder US Vaccine Uptake

Brian Nowosielski
March 11th 2025
Article

IQVIA released a report detailing pharmacists’ authority to administer vaccines in the US as well as adults’ overall vaccination rates by state.

Access to Community Pharmacies Increased Willingness to Receive Flu Vaccine

Access to Community Pharmacies Increased Willingness to Receive Flu Vaccine

Brian Nowosielski
March 5th 2025
Article

Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients’ willingness to return for future immunization.

© 2025 MJH Life Sciences

All rights reserved.